Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Cited by (1,000)

Items 601–700 of 1,000

1. Structural Studies of Epithelial Mesenchymal Transition Breast Tissues
   S. N. Mohd Sobri, Siti Fairus Abdul Sani, Siti Norbaini Sabtu, Lai‐Meng Looi, Seow-Fan Chiew, Dharini Pathmanathan, Sirinart Chio‐Srichan, David Andrew Bradley · 2020 · Scientific Reports
2. Mesenchymal stem cells reduce alcoholic hepatitis in mice via suppression of hepatic neutrophil and macrophage infiltration, and of oxidative stress
   Yue‐Meng Wan, Zhiqiang Li, Chang Liu, Yuefeng He, Men-Jie Wang, Xinan Wu, Yuan Zhang, Yuhua Li · 2020 · PLoS ONE
3. The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD
   Ariel Sasson, Eva Kristoferson, Rogério Oliveira Batista, John Arthur McClung, Nader G. Abraham, Stephen J. Peterson · 2020 · Archives of Biochemistry and Biophysics
4. Orally administered saccharide-sequestering nanocomplex to manage carbohydrate metabolism disorders
   Xin Zhao, Huijun Zhang, Jiacheng Li, Meng Tian, Juanjuan Yang, Songxuan Sun, Qixin Hu, Yang Liu, Shiyi Zhang · 2021 · Science Advances
5. Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)
   Giada Sebastiani, Keyur Patel, Vlad Ratziu, Jordan J. Feld, Brent A. Neuschwander‐Tetri, Massimo Pinzani, Salvatore Petta, Annalisa Berzigotti, Peter P. Metrakos, Naglaa H. Shoukry et al. · 2021 · Canadian Liver Journal
6. Screening for NAFLD—Current Knowledge and Challenges
   Roberta Forlano, Giordano Sigon, Benjamin Harvey Mullish, Michael S. Yee, Pinelopi Manousou · 2023 · Metabolites
7. Morin inhibits the activity of pancreatic lipase and adipogenesis
   Venkateish Vp, Rajamanikandan Sundarraj, Madan Kumar Perumal · 2024 · European Journal of Pharmacology
8. Protective Effects of Korean Red Ginseng against Alcohol-Induced Fatty Liver in Rats
   Hyo Won Lee, Hyang Mok Ok, Oran Kwon · 2015 · Molecules
9. Dietary treatment of nonalcoholic steatohepatitis
   Emily Rothbaum Perito, Luis A. Rodríguez, Robert H. Lustig · 2012 · Current Opinion in Gastroenterology
10. bZIP transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review)
    MIN WANG, Shui-Ping Zhao, MINGYUE TAN · 2015 · Molecular Medicine Reports
11. Markers in Nonalcoholic Steatohepatitis
    Ferah Armutçu, Sümeyya Akyol, Fatma Uçar, Serpil Erdoğan, Ömer Akyol · 2013 · Advances in clinical chemistry
12. Molecular mechanism of hepatic steatosis: pathophysiological role of autophagy
    Ke‐wei Wang · 2016 · Expert Reviews in Molecular Medicine
13. Distinct Hepatic Macrophage Populations in Lean and Obese Mice
    Rafael Mayoral, Andrew M. F. Johnson, Olivia Osborn, Paqui G. Través, Sushil Kumar Mahata · 2016 · Frontiers in Endocrinology
14. Serum adipocyte fatty acid‐binding protein levels: An indicator of non‐alcoholic fatty liver disease in Chinese individuals
    Yiting Xu, Xiaojing Ma, Xiaoping Pan, Xingxing He, Yufei Wang, Yuqian Bao · 2018 · Liver International
15. Transcription Coactivator BCL3 Acts as a Potential Regulator of Lipid Metabolism Through the Effects on Inflammation
    Shuo Zhang, Jingtao Gao, Shibo Liu, Yu Lu, Wen Zhang, Yinming Liang, Hui Wang · 2021 · Journal of Inflammation Research
16. Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver
    Pi‐Jung Hsiao, Zhih-Cherg Chen, Wei‐Wen Hung, Yi‐Hsin Yang, Mei‐Yueh Lee, Jee‐Fu Huang, Kung‐Kai Kuo · 2013 · BMC Medical Genetics
17. Treatment of cigarette smoke extract and condensate differentially potentiates palmitic acid-induced lipotoxicity and steatohepatitis in vitro
    Zixiong Zhou, Jong Won Kim, Jing Zhao, Jing Qi, Seong Jin Choi, Chae Woong Lim, Moo‐Yeol Lee, Kyuhong Lee, Bumseok Kim · 2018 · Toxicology in Vitro
18. TREM2 in MASH: integrating lipid metabolism and immune response
    Shuyi Shi, Yangyang Y. Zhou, Haiming Zhang, Junli Zhang · 2025 · Frontiers in Immunology
19. Association between longitudinal weight change and clinical outcome in individuals with MASLD
    Yu Shi, Ruoqi Zhou, Seung Up Kim, Terry Cheuk‐Fung Yip, Emmanuel A. Tsochatzis, Salvatore Petta, Atsushi Nakajima, Hannes Hagström, Elisabetta Bugianesi, Wah‐Kheong Chan et al. · 2025 · Hepatology
20. Endoplasmic reticulum stress at the forefront of fatty liver diseases and cancer
    Michael Karin, Ju Youn Kim · 2025 · Pharmacological Reviews
21. Eriodictyol 7-O-β-D glucopyranoside from Coreopsis tinctoria Nutt. ameliorates lipid disorders via protecting mitochondrial function and suppressing lipogenesis
    Yuyan Liang, Hai Niu, Limei Ma, Dan Du, Li Wen, Qing Xia, Wen Qing Huang · 2017 · Molecular Medicine Reports
22. Bioactive dipeptide from potato protein hydrolysate combined with swimming exercise prevents high fat diet induced hepatocyte apoptosis by activating PI3K/Akt in SAMP8 mouse
    Pei‐Fang Lai, Rathinasamy Baskaran, Chia‐Hua Kuo, Cecilia Hsuan Day, Ray‐Jade Chen, Tsung‐Jung Ho, Yu‐Lan Yeh, V. Vijaya Padma, Chin‐Hu Lai, Chih‐Yang Huang · 2021 · Molecular Biology Reports
23. Association between flavonoid and subclasses intake and metabolic associated fatty liver disease in U.S. adults: Results from National Health and Nutrition Examination Survey 2017–2018
    Junlu Tong, Yingjuan Zeng, Jianhui Xie, Kecen Xiao, Man Li, Li Cong · 2022 · Frontiers in Nutrition
24. Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction–associated fatty liver disease
    Kangning Zheng, Wenhan Zhou, Jingmin Ji, Yu Xue, Yiwei Liu, Caige Li, Zhiqin Zhang, Junlan Lu, Xinli Shi, Yongmin Li · 2023 · Journal of Ethnopharmacology
25. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review
    Marta Bento Afonso, Jan Caira David, Mariana I. Alves, André Anastácio Santos, Gonçalo Campino, Vlad Ratziu, Jérémie Gautheron, Cecília M. P. Rodrigues · 2024 · Metabolism
26. Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease
    Sneha Muralidharan, Jonathan Wei Jie Lee, Yee Siang Lim, Mark Dhinesh Muthiah, Eunice Tan, Deniz Demicioglu, Asim Shabbir, Wai Mun Loo, Chieh Sian Koo, Yin Mei Lee et al. · 2024 · Metabolism
27. Intestinal GATA4 deficiency protects from diet-induced hepatic steatosis
    Jay V. Patankar, Sascha Obrowsky, Prakash Doddapattar, Gerald Höefler, Michele A. Battle, Sanja Levak‐Frank, Dagmar Kratky · 2012 · Journal of Hepatology
28. Extracellular Vesicles as Messengers Between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis
    Jörn Markus Schattenberg, Myung‐Shik Lee · 2016 · Gastroenterology
29. Changes in the immune system – the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease
    Marcin Kosmalski, Łukasz Mokros, Piotr Kuna, Andrzej Witusik, Tadeusz Pietras · 2018 · Central European Journal of Immunology
30. Molybdate Attenuates Lipid Accumulation in the Livers of Mice Fed a Diet Deficient in Methionine and Choline
    Seung‐Woo Lee, Ki‐Hoan Nam, Je Kyung Seong, Doug‐Young Ryu · 2018 · Biological and Pharmaceutical Bulletin
31. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
    Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina · 2020 · SAGE Open Medicine
32. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea
    Esther Rey, Elvira Del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García‐García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García‐Monzón, Isaac Almendros et al. · 2020 · Frontiers in Medicine
33. Farnesoid X Receptor Agonists: What They Are and How They Might Be Used in Treating Liver Disease
    Brent A. Neuschwander‐Tetri · 2011 · Current Gastroenterology Reports
34. Plasma fatty acid lipidome is associated with cirrhosis prognosis and graft damage in liver transplantation
    Stefano Ginanni Corradini, Chiara Zerbinati, Federica Maldarelli, Giuseppina Palmaccio, Lucia Parlati, Anna Giulia Bottaccioli, Antonio Molinaro, Edoardo Poli, Mona Boaz, Gaetano Serviddio et al. · 2014 · American Journal of Clinical Nutrition
35. Influence of hyperglycemia on liver inflammatory conditions in the early phase of non-alcoholic fatty liver disease in mice
    Shinichi Harada, Kei Miyagi, Tokio Obata, Yasuko M. Morimoto, Kazuo Nakamoto, Ke Ih Kim, Soo Ki Kim, Soo Ryang Kim, Shogo Tokuyama · 2017 · Journal of Pharmacy and Pharmacology
36. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH
    Khoury, Mireille, Guo, Qianqian, Furuta, Kunimaro, Correia, Cristina, Meroueh, Chady, Kim Lee, Hyun Se, Warasnhe, Khaled, Valenzuela-Pérez, Lucía, Mazar, Andrew P., Kim, Iljung et al. · 2024 · JHEP Reports
37. Oxidative Stress Causes Masculinization of Genetically Female Medaka Without Elevating Cortisol
    Koki Mukai, Seiji Hara, Konosuke Sakima, Ryo Nozu, Takashi Yazawa, Takeshi Kitano · 2022 · Frontiers in Endocrinology
38. Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease
    Xi Liu, Yuyun Jiang, Jixian Ye, Xuefeng Wang · 2022 · Frontiers in Immunology
39. Exogenous hydrogen sulfide alleviates hepatic endoplasmic reticulum stress via SIRT1 / FoxO1 / PCSK9 pathway in NAFLD
    Xiaomeng Cui, Menglin Yao, Yanjing Feng, Chengjun Li, Yarui Li, Dan Guo, Shuixiang He · 2023 · The FASEB Journal
40. The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease
    Zhichi Li, Dantong Zheng, Tiantian Zhang, Shan Ruan, Na Li, Yu Yang, Peng Yang, Difei Wang · 2023 · Hepatology Communications
41. Pathogenesis of Nonalcoholic Fatty Liver Disease
    Mariana Verdelho Machado, Anna Mae Diehl · 2018 · Elsevier eBooks
42. Treatment Options in Non-alcoholic Fatty Liver Disease
    Won Kyum Kim · 2017 · Korean Journal of Gastroenterology
43. The antipsychotics sulpiride induces fatty liver in rats via phosphorylation of insulin receptor substrate-1 at Serine 307-mediated adipose tissue insulin resistance
    Xia Zhou, Liying Ren, Zhi‐Ling Yu, Xiaoqian Huang, Yuhao Li, Chunxia Wang · 2018 · Toxicology and Applied Pharmacology
44. Upregulation of non-canonical Wnt ligands and oxidative glucose metabolism in NASH induced by methionine-choline-deficient diet
    Lixin Zhu, Abdul Shahein, Shelly Choudhury, Wensheng Liu, Tavleen Bhatia, Robert D. Baker, Techung Lee, Susan S. Baker · 2018 · Trends in Cell & Molecular Biology
45. Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models
    Qiongya Zhao, 杭州医学院检验医学院，浙江 杭州310053，中国, Linghong Ge, Kun Zhang, Hai-Feng Chen, Xin-Xin Zhan, Yue Jin Yang, Qing-Lin Dang, Yi Zheng, Huaibin Zhou et al. · 2020 · 动物学研究
46. MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits
    Erik N. Taylor, Nasi Huang, Jacob Bodde, Andrew Ellison, Ronald Killiany, Markus Michael Bachschmid, James A. Hamilton · 2018 · Journal of Translational Medicine
47. Differential response of liver sinusoidal endothelial cells and hepatocytes to oleic and palmitic acid revealed by Raman and CARS imaging
    Ewelina Matuszyk, Ewa Sierka, Marko Rodewald, Hyeonsoo Bae, Tobias Meyer, Edyta Kuś, Stefan Chłopicki, Michael P. Schmitt, Jürgen Popp, Małgorzata Barańśka · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
48. Black bean protein concentrate ameliorates hepatic steatosis by decreasing lipogenesis and increasing fatty acid oxidation in rats fed a high fat-sucrose diet
    Irma Hernández-Velázquez, Mónica Sánchez‐Tapia, Guillermo Ordáz‐Nava, Nimbe Torres, Armando Roberto Tovar, Amanda Gálvez Mariscal · 2020 · Food & Function
49. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics
    Forkan Ahamed, Natalie Eppler, Elizabeth Jones, Yuxia Zhang · 2024 · Livers
50. Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models
    María Pelechá-Salvador, Estela Villanueva-Bádenas, Enrique Timor-López, María Teresa Donato, Laia Tolosa · 2021 · Antioxidants
51. Multiomics analysis of the impact of polychlorinated biphenyls on environmental liver disease in a mouse model
    B. Petri, K. Piell, B. Wahlang, K. Z. Head, K. Andreeva, E. Rouchka, Jian-Min Pan, S. Rai, M. Cave, C. Klinge · 2022 · Environmental Toxicology and Pharmacology
52. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
    Ahmed M. Kabel, Maaly A. Abd Elmaaboud, Ahmed A. Albarraq · 2014 · Prostaglandins Leukotrienes and Essential Fatty Acids
53. Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis
    Baoqing Liu, Xiaoxiang Mao, Dandan Huang, Fei Yue Li, Nianguo Dong · 2019 · Diabetes Metabolic Syndrome and Obesity
54. Evaluation of the functional quality of rapeseed oil obtained by different extraction processes in a Sprague-Dawley rat model
    Youdong Li, Liang Zhang, Yong‐Jiang Xu, Jinwei Li, Peirang Cao, Yuanfa Liu · 2019 · Food & Function
55. Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children
    Xiucui Han, Pengfei Xu, Jianming Zhou, Yongxia Liu, Huiyan Xu · 2020 · Diabetes Research and Clinical Practice
56. Investigating pharmacological mechanisms of andrographolide on non-alcoholic steatohepatitis (NASH): A bioinformatics approach of network pharmacology
    Lei Li, Shenghe Li, Jinpeng Jiang, Chang Liu, Lili Ji · 2021 · Chinese Herbal Medicines
57. Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice
    Kosuke Ishida, Akihiro Seki, Kazunori Kawaguchi, Alessandro Nasti, Masatoshi Yamato, Hiiro Inui, Takuya Komura, Taro Yamashita, Kuniaki Arai, Tatsuya Yamashita et al. · 2021 · Stem Cell Research
58. The microbial metabolome in metabolic‐associated fatty liver disease
    Mengci Li, Cynthia Rajani, Xiaojiao Zheng, Wei Ping Jia · 2021 · Journal of Gastroenterology and Hepatology
59. Mechanisms of Gynostemma pentaphyllum against non‐alcoholic fibre liver disease based on network pharmacology and molecular docking
    Cunzhi Wang, Pengrui Wang, Wenbin Chen, Yanyan Bai · 2022 · Journal of Cellular and Molecular Medicine
60. Heat Shock Protein 27 is down-regulated in Ballooned Hepatocytes of Patients with Nonalcoholic Steatohepatitis (NASH)
    Silvia Sookoian, Gustavo Osvaldo Castaño, Romina Scian, Julio San Martino, Carlos Jose Pirola · 2016 · Scientific Reports
61. Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro
    Khalida Ann Lockman, Varanand Htun, Rohit Sinha, Philipp Treskes, Leonard J. Nelson, Sarah F. Martin, Sophie M. Rogers, Thierry Le Bihan, Peter Clive Hayes, John N. Plevris · 2016 · Lipids in Health and Disease
62. Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models
    Anna Cleta Croce, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Valeria Maria Piccolini, Vittorio Bertone, Giovanni F. Bottiroli, Mariapia Vairetti · 2016 · Journal of Photochemistry and Photobiology B Biology
63. Changes in extrapulmonary organs and serum enzyme biomarkers after chronic exposure to Buenos Aires air pollution
    Guillermo A. Maglione, Melisa Kurtz, Nadia Soledad Orona, Francisco Astort, Fernando Daniel Brites, Celina Morales, Alejandro Berra, Deborah R. Tasat · 2020 · Environmental Science and Pollution Research
64. Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
    Himani Pandey, Prabudh Goel, Varunvenkat M. Srinivasan, Daryl W. T. Tang, Sunny H Wong, Devi Lal · 2025 · World Journal of Hepatology
65. The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population—A Review
    Thomas Pixner, Nathalie Stummer, Anna-Maria Schneider, Andreas Lukas, Karin Gramlinger, Valérie Julian, David Thivel, Katharina Mörwald, Katharina Maruszczak, Harald Mangge et al. · 2022 · Life
66. Untargeted Lipidomics Revealed the Protective Effects of Cyanidin-3-O-glucoside on Bisphenol A-Induced Liver Lipid Metabolism Disorder in Rats
    Ruijing Liu, Yulong Jin, Bo Liu, Qing Zhang, Xusheng Li, Dongbao Cai, Lingmin Tian, Xinwei Jiang, Wenbao Zhang, Jianxia Sun et al. · 2023 · Journal of Agricultural and Food Chemistry
67. Protective effects of caffeine against palmitate-induced lipid toxicity in primary rat hepatocytes is associated with modulation of adenosine receptor A1 signaling
    Johanna C. Arroyave-Ospina, Manon Buist‐Homan, Martina Schmidt, Han J. Moshage · 2023 · Biomedicine & Pharmacotherapy
68. Changes in m6A in Steatotic Liver Disease
    Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge · 2023 · Genes
69. Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease
    Yi Pan, Yunxiao Zhang, Hongling Ouyang, Tao Gong, Zhirong Zhang, Xi Cao, Yao Shi Fu · 2023 · ACS Applied Bio Materials
70. Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice
    Xiaoju Shi, Qianqian Zheng, Xingtong Wang, Wei Guo, Ziqi Lin, Yonglin Gao, Emily A. Shore, Robert C.G. Martin, Guoyue Lv, Yan Li · 2024 · Science Advances
71. Exercise, exerkines and exercise mimetic drugs: Molecular mechanisms and therapeutics.
    Vedant Samant, Arati Prabhu · 2024 · Life Science
72. The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful
    Agnes Molnar, Johannes Haybaeck, Carolin Lackner, Pavel Strnad · 2011 · Expert Review of Gastroenterology & Hepatology
73. Obesity-related gut hormones and cancer: novel insight into the pathophysiology
    Maria Angela Guzzardi, Gabriella Pugliese, Filomena Bottiglieri, Caterina Pelosini, Giovanna Muscogiuri, Luigi Barrea, Silvia Savastano, Annamaria Colao · 2021 · International Journal of Obesity
74. Cystic fibrosis related liver disease and endocrine considerations
    Jordan S. Sherwood, Jagdeesh Ullal, KATHERINE A. KUTNEY, Kara S. Hughan · 2021 · Journal of Clinical & Translational Endocrinology
75. Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis
    Archana Vijayakumar, Ayşe Ökesli, Ting Wang, Isabel A. Olson, Minji Seung, Saritha Kusam, David Hollenback, Sangeetha Mahadevan, Bruno Marchand, Maria M. Toteva et al. · 2022 · Hepatology Communications
76. Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota
    Lin Ji, Huan Deng, Huimin Xue, Jiting Wang, Kexin Hong, Yunxiao Gao, Xiping Kang, Guanghe Fan, Weidong Huang, Jicheng Zhan et al. · 2023 · Comprehensive Reviews in Food Science and Food Safety
77. HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis
    Yang Yang, Xian Liu, Hui Chen, Pengjun Wang, Songhui Yao, Bin Zhou, Ronghua Yin, Chang‐Yan Li, Chutse Wu, Xiaoming Yang et al. · 2022 · FEBS Journal
78. Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis
    Yuko Tsukahara, Beatriz Ferrán, Erika T. Minetti, Brian S. H. Chong, Adam C. Gower, Markus Michael Bachschmid, Reiko Matsui · 2022 · Antioxidants
79. Hepatic DKK1-driven steatosis is CD36 dependent
    Zhen Yang, Xinping Huang, Jiaye Zhang, Kai You, Yue Xiong, Fang Ji, Anteneh Getachew, Ziqi Cheng, Xiaorui Yu, Yan Wang et al. · 2022 · Life Science Alliance
80. Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease
    Jeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, Kristian Løkke Funck, Esben Søndergaard, Rakel Fuglsang Johansen, Steffen Ringgaard, Lars Poulsen Tolbod, Mogens Johannsen, Helle Kanstrup et al. · 2023 · Atherosclerosis
81. Cholesterol Exacerbates the Pathophysiology of Non-Alcoholic Steatohepatitis by Upregulating Hypoxia-Inducible Factor 1 and Modulating Microcirculatory Dysfunction
    Evelyn Nunes Goulart da Silva Pereira, Beatriz Peres de Araujo, Karine Lino Rodrigues, Raquel Rangel Silvares, Fernanda Verdini Guimarães, Carolina Souza Machado Martins, Edgar Eduardo Ilaquita Flores, Patrı́cia Silva, Anissa Daliry · 2023 · Nutrients
82. Analysis of the association between urinary glyphosate exposure and fatty liver index: a study for US adults
    Kexing Han, Long Gao, Honghai Xu, Jiali Li, Lianxiu Han, Jiapei Shen, Weijie Sun, Yufeng Gao · 2024 · BMC Public Health
83. Moringa oleifera L. mediated zinc oxide nano-biofertilizer alleviates non-alcoholic steatohepatitis via modulating de novo lipogenesis pathway and miRNA-122 expression
    Dina Mostafa Mohammed, Maha Badr Salem, Mohamed Elzallat, Olfat Ali Hammam, Ahmad A. Suliman · 2024 · Food Bioscience
84. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis
    Sayuri Takada, Tsutomu Matsubara, Hideki Fujii, Misako Sato-Matsubara, Atsuko Daikoku, Naoshi Odagiri, Yuga Amano‐Teranishi, Norifumi Kawada, Kazuo Ikeda · 2020 · Laboratory Investigation
85. Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue
    Sujeong Park, Jinsoo Song, In‐Jeoung Baek, Kyu Yun Jang, Chang Yeob Han, Dae Won Jun, Peter Kijun Kim, Brian Raught, Eun‐Jung Jin · 2021 · Experimental & Molecular Medicine
86. Procyanidin B2 Alleviates Palmitic Acid-Induced Injury in HepG2 Cells via Endoplasmic Reticulum Stress Pathway
    Yiming Li, Shao-Yang Zhao, Huanhuan Zhao, Baohua Wang, Saimei Li · 2021 · Evidence-based Complementary and Alternative Medicine
87. Macrovesicular steatosis is associated with development of lobular inflammation and fibrosis in diet-induced non-alcoholic steatohepatitis (NASH)
    Petra Mulder, Liang, W., Wielinga, P.Y., Verschuren, L., Karin H. Toet, Louis M. Havekes, Anita M. van den Hoek, Robert Kleemann · 2015 · Inflammation and Cell Signaling
88. Sulforaphane protects human umbilical vein cells against lipotoxicity by stimulating autophagy via an AMPK-mediated pathway
    Ning Wang, Juyang Zhao, Qian Liu, Xinping Diao, Baohua Kong · 2015 · Journal of Functional Foods
89. Should We Lower Lipids in Nonalcoholic Fatty Liver Disease?
    Geoffrey C. Farrell · 2013 · Clinical Gastroenterology and Hepatology
90. Aspects of transition cow metabolomics—Part II: Histomorphologic changes in the liver parenchyma throughout the transition period, in cows with different liver metabotypes and effects of a metaphylactic butaphosphan and cyanocobalamin treatment
    Fabian Pietsch, Melanie Schären, Teja Snedec, Kirsten B. Theinert, Anne-Sophie Leonhardt, A. Kaiser, Fanny Rachidi, Denny Böttcher, Jan Scheinert, H.-A. Schoon et al. · 2021 · Journal of Dairy Science
91. 55-Week Treatment of Mice with theUnaniandAyurvedicMedicine Pomegranate Flower Ameliorates Ageing-Associated Insulin Resistance and Skin Abnormalities
    Jianwei Wang, Xianglu Rong, Irene S. I. Um, Johji Yamahara, Yuhao Li · 2011 · Evidence-based Complementary and Alternative Medicine
92. Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
    Shengyu Zhang, Congcong Shen, Di Han, Yanhong Wang, Feng Guan · 2025 · Antioxidants
93. Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis
    Yoshihiko Terashima, Shin Nishiumi, Akihiro Minami, Yuki Kawano, Namiko Hoshi, Takeshi Azuma, Masaru Yoshida · 2014 · Archives of Biochemistry and Biophysics
94. The Effect of Combined Diet Containing n-3 Polyunsaturated Fatty Acids and Silymarin on Metabolic Syndrome in Rats
    Martin Poruba, Pavel Anzenbacher, Zuzana Rácová, Olena Oliyarnyk, Martina Hüttl, Hana Malínská, Irena Marková, Soňa Gurská, Ludmila Kazdová, Rostislav Večeřa · 2019 · Physiological Research
95. Exploring the Role of Bempedoic Acid in Metabolic Dysfunction Associated Steatotic Liver Disease: Actual Evidence and Future Perspectives
    Elena Butera, Fabrizio Termite, Giorgio Esposto, Linda Galasso, Irene Mignini, Raffaele Borriello, Maria Elena Ainora, Luca Miele, Antonio Gasbarrini, Maria Assunta Zocco · 2024 · International Journal of Molecular Sciences
96. TRIM24 Up-Regulates ORM2 to Alleviate Abnormal Lipid Metabolism, Inflammation, and Oxidative Stress in Mice with Obstructive Sleep Apnea Syndrome and Metabolic Dysfunction–Associated Steatotic Liver Disease
    Hui Zhang, Si Lei, Hui Zhuo, Yan Xu, Yun Ye, Yingquan Luo · 2024 · American Journal Of Pathology
97. Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype
    Elisa Alchera, Chiara Imarisio, Giorgia Mandili, Simone Merlin, Bangalore R. Chandrashekar, Francesco Novelli, Antonia Follenzi, Rita Carini · 2015 · BioMed Research International
98. Management and diagnosis of fatty liver disease
    Amanda Schneier, Caitlin Citti, Douglas T. Dieterich · 2015 · Expert Review of Gastroenterology & Hepatology
99. Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH
    Ying Lu, Xiaolan Su, Manyu Zhao, Qianru Zhang, Chuang Liu, Qinhuai Lai, Sijia Wu, Aiping Fang, Jinliang Yang, Xiaoxin Chen et al. · 2019 · PeerJ
100. Mouse models of nonalcoholic steatohepatitis and their application to new drug development
     Huy Hieu Phung, Chang Hoon Lee · 2022 · Archives of Pharmacal Research